A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis

Jane R. Schwebke, Belvia A. Carter, Arthur S. Waldbaum, Kathy J. Agnew, Jeremy R.A. Paull, Clare F. Price, Alex Castellarnau, Philip McCloud, George R. Kinghorn
doi: https://doi.org/10.1101/2020.08.06.20159475

Data Availability

The data that support the findings of this study are available from the corresponding author (JRAP) upon reasonable request.

Back to top
Posted October 01, 2020.
Download PDF
Data/Code
Email
A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis
Jane R. Schwebke, Belvia A. Carter, Arthur S. Waldbaum, Kathy J. Agnew, Jeremy R.A. Paull, Clare F. Price, Alex Castellarnau, Philip McCloud, George R. Kinghorn
medRxiv 2020.08.06.20159475; doi: https://doi.org/10.1101/2020.08.06.20159475
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area